PhoreMost™ is focused on bringing more effective and affordable targeted medicines to patients.

PhoreMost™ is a new-model drug discovery company based in Cambridge, UK: Using its core expertise to open up new ‘druggable’ target space and working with a global network of co-invested academic and industrial collaboration partners, we aim to bring a wide array of novel ‘targeted’ therapies more efficiently to market and pass these cost savings onto patients.


PhoreMost’s first drug discovery program is based on a novel target that addresses the “undruggable” cancer gene KRAS, which affects multiple types of cancer.  This program is now entering the lead optimisation phase and PhoreMost™ will be seeking partners for its further development by H2 2015.

Stay up to date with PhoreMost

Login or create a free user account to follow this company and see updates on your dashboard.

Create account